Pharmacyclics, Inc. News Headlines

Get PCYC Alerts
*Delayed - data as of Oct. 30, 2014 12:24 ET  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PCYC Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By
The Time Is Now For Northwest Biotherapeutics
10/29/2014 3:16:00 PM - Seeking Alpha

Buy These 5 Breakout Health Care Stocks for Healthy Gains
10/28/2014 10:30:00 AM - TheStreet

Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog
10/22/2014 1:54:00 PM - Zacks.com

NBIX For The Long Haul, RegeneRx Catches Investors' Eyes, NewLink Inks New Deal
10/20/2014 11:47:00 PM - RTT News

Sector Update: Health Stocks Higher Pre-Bell
10/20/2014 8:54:23 AM - MT Newswires

Sector Update: Health Care
10/20/2014 8:53:17 AM - MT Newswires

Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog
10/17/2014 6:15:00 PM - Zacks.com

Sector Update: Health Stocks Higher Pre-Bell
10/17/2014 9:21:20 AM - MT Newswires

Sector Update: Health Care
10/17/2014 9:19:42 AM - MT Newswires

IMBRUVICA Gets Marketing Approval From EC For Treatment Of Two Blood Cancers
10/17/2014 9:14:00 AM - RTT News

AFFX In Harmony, SRPT, IBIO Focusing On Ebola, PCYC Inks Deal With Roche
10/17/2014 12:53:00 AM - RTT News

Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
10/15/2014 8:45:02 AM - Motley Fool

Bristol-Myers Collaborates for Opdivo-Imbruvica Combo - Analyst Blog
10/14/2014 5:20:00 PM - Zacks.com

Interesting PCYC Put And Call Options For January 2017
10/13/2014 11:56:47 AM - BNK Invest

Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA
10/13/2014 8:28:00 AM - RTT News

15 Surprising Cancer Statistics
10/12/2014 9:41:02 AM - Motley Fool

Stocks Under Pressure Amid Global Economic Concerns - U.S. Commentary
10/7/2014 10:25:00 AM - RTT News

Individual Investor Portfolio: Major Sectors Are Beginning To Move In Opposing Directions
10/4/2014 3:39:00 AM - Seeking Alpha

Gilead Sciences, Inc. Stock's Stunning New Opportunity
9/30/2014 9:15:02 AM - Motley Fool

FDA Decision On Imbruvica Will Push Pharmacyclics Higher
9/29/2014 1:32:00 PM - Seeking Alpha

Cramer's Lightning Round - People Need H&R Block More Than Ever (9/17/14)
9/18/2014 4:53:00 AM - Seeking Alpha

Modest Weakness Remains Visible On Wall Street - U.S. Commentary
9/11/2014 12:04:00 PM - RTT News

Stocks Remain Nearly Flat In Mid-Day Trading - U.S. Commentary
9/10/2014 12:16:00 PM - RTT News

Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News
9/3/2014 6:47:20 PM - Zacks.com

Gilead: Rising Short Interest Provides Yet Another Reason To Own The Stock
8/15/2014 2:40:00 PM - Seeking Alpha